Veröffentlichungen
Originalarbeiten, Bücher, Buchkapitel und Übersichtsartikel von Prof. Marcus Maurer
Verwendung: Beginnen Sie mit einer Übersicht über alle Publikationen. Verwenden Sie Tag-Links, um markierte Dokumente aufzulisten oder eine ganze Kategorie aufzulisten, z.B. Original Work (Originalarbeiten), Books (Bücher), Book Chapters (Buchkapitel), Reviews (Übersichtsartikel). Wenn Sie wissen, was Sie suchen, dann geben Sie diesen Begriff in das Suchfeld ein.
Role of substance P and its receptor neurokinin 1 in chronic prurigo: a randomized, proof-of-concept, controlled trial with topical aprepitant
Filename | 292. Ohanyan et al., ITAPP Role Subst. P, ADV2018.pdf |
Filesize | 1,22 MB |
Version | o.292 |
Date added | Juli 29, 2020 |
Downloaded | 0 times |
Category | Original Work |
Tags | aprepitant, lesional skin, NK1R, prurigo, pruritus intensity, substance P |
Authors | Ohanyan, T., Schoepke, N., Eirefelt, S., Hoey, G., Koopmann, W., Hawro, T., Maurer, M. and Metz, M. |
Citation | Ohanyan, T., Schoepke, N., Eirefelt, S., Hoey, G., Koopmann, W., Hawro, T., Maurer, M. and Metz, M.: Role of substance P and its receptor neurokinin 1 in chronic prurigo: a randomized, proof-of-concept, controlled trial with topical aprepitant. Acta Derm. Venereol. 2018: 98; 26-31. |
Corresponding authors | Metz, M. |
DocNum | O.292 |
DocType | |
Edition; Page | 98; 26-31 |
IF | 3.53 |
Publisher | Acta Derm. Venereol. |
ReleaseDate | 2018 |
Substance P (SP) and its receptor neurokinin 1 (NK1R) are thought to be involved in the pathogenesis of chronic prurigo. Here, we assessed SP serum levels, cutaneous NK1R expression, and the effects of topical aprepitant, an NK1R antagonist, in patients with chro- nic prurigo. SP and NK1R were increased, compared with controls, in the serum and in lesional vs. non-le- sional skin of the patients, respectively. Aprepitant, in a randomized, placebo-controlled, split-sided, double- blind trial, reduced the intensity of pruritus as asses- sed by visual analogue scale by >50% from baseline to day 28 (–35.2), but so did placebo vehicle (–38.1, p = 0.76). Overall clinical scores improved significantly by day 28 in both treatment groups, with no signifi- cant difference between the 2 groups (p=0.32). Our findings imply that both SP and NK1R are involved in the pathogenesis of chronic prurigo. Parallel group- designed trials are needed to assess the efficacy of to- pical aprepitant treatment in this condition.
(Last update: 12.2023)
Number of original publications in peer-reviewed journals: | 580 |
Number of reviews in peer-reviewed journals: | 210 |
Number of publications (original work and reviews) in peer-reviewed journals: | 790 |
Cumulative IF for original publications in peer-reviewed journals: | 4196.39 |
Cumulative IF for reviews in peer-reviewed journals: | 1409.32 |
Cumulative IF of publications (original work & reviews) in peer-reviewed journals: | 5605.71 |
Total number of citations: 36,836, h-index: 99 (Web of Science December 2023) | 36836 |
Download-Information
Um die angebotenen Veröffentlichungen herunterladen zu können, müssen Sie sich einloggen. Wenn Sie das Login nicht kennen, schreiben Sie mir bitte Ihre Anfrage.